Gene · 9507
Papers2,479
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
701 to 720 of 2,479
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Disintegrin and Metalloproteinase (ADAM) Family: Their Significance in Malignant Tumors of the Central Nervous System (CNS). | Int J Mol Sci | 2021 | 34638718 | PubTator, text mining | PubMed |
| The diagnostic indicators of gestational diabetes mellitus from second trimester to birth: a systematic review. | Clin Diabetes Endocrinol | 2021 | 34635186 | PubTator, text mining | PubMed |
| Systems biology approaches to unravel the molecular and genetic architecture of Alzheimer's disease and related tauopathies. | Neurobiol Dis | 2021 | 34634459 | PubTator, text mining | PubMed |
| miR-489-3p overexpression inhibits lipopolysaccharide-induced nucleus pulposus cell apoptosis, inflammation and extracellular matrix degradation via targeting Toll-like receptor 4. | Exp Ther Med | 2021 | 34630677 | PubTator, text mining | PubMed |
| Soluble biological markers in osteoarthritis. | Ther Adv Musculoskelet Dis | 2021 | 34616494 | PubTator, text mining | PubMed |
| Transcriptional profiling of intervertebral disc in a post-traumatic early degeneration organ culture model. | JOR Spine | 2021 | 34611583 | PubTator, text mining | PubMed |
| circSPG21 protects against intervertebral disc disease by targeting miR-1197/ATP1B3. | Exp Mol Med | 2021 | 34611269 | PubTator, text mining | PubMed |
| A New Survival Model Based on ADAMTSs for Prognostic Prediction in Clear Cell Renal Cell Carcinoma. | J Oncol | 2021 | 34603444 | PubTator, text mining | PubMed |
| Melatonin Maintains Anabolic-Catabolic Equilibrium and Regulates Circadian Rhythm During Osteoarthritis Development in Animal Models: A Systematic Review and Meta-analysis. | Front Pharmacol | 2021 | 34603028 | PubTator, text mining | PubMed |
| Role of circular RNAs in osteoarthritis (Review). | Exp Ther Med | 2021 | 34594416 | PubTator, text mining | PubMed |
| Development of a fluorogenic ADAMTS-7 substrate. | J Enzyme Inhib Med Chem | 2021 | 34587841 | PubTator, text mining | PubMed |
| Inhibition of nuclear receptor RORα attenuates cartilage damage in osteoarthritis by modulating IL-6/STAT3 pathway. | Cell Death Dis | 2021 | 34584074 | PubTator, text mining | PubMed |
| The Interaction between microRNAs and the Wnt/β-Catenin Signaling Pathway in Osteoarthritis. | Int J Mol Sci | 2021 | 34576049 | PubTator, text mining | PubMed |
| Adipose-Derived Extract Suppresses IL-1β-Induced Inflammatory Signaling Pathways in Human Chondrocytes and Ameliorates the Cartilage Destruction of Experimental Osteoarthritis in Rats. | Int J Mol Sci | 2021 | 34575945 | PubTator, text mining | PubMed |
| Combining stretching and gallic acid to decrease inflammation indices and promote extracellular matrix production in osteoarthritic human articular chondrocytes. | Exp Cell Res | 2021 | 34563516 | PubTator, text mining | PubMed |
| miR-19b-3p relieves intervertebral disc degeneration through modulating PTEN/PI3K/Akt/mTOR signaling pathway. | Aging (Albany NY) | 2021 | 34554926 | PubTator, text mining | PubMed |
| Transcription factor Krüppel-like factor 5-regulated N-myc downstream-regulated gene 2 reduces IL-1β-induced chondrocyte inflammatory injury and extracellular matrix degradation. | Bioengineered | 2021 | 34551684 | PubTator, text mining | PubMed |
| MicroRNA-338-3p as a novel therapeutic target for intervertebral disc degeneration. | Exp Mol Med | 2021 | 34531509 | PubTator, text mining | PubMed |
| Studies on the Role of circRNAs in Osteoarthritis. | Biomed Res Int | 2021 | 34527744 | PubTator, text mining | PubMed |
| Extracellular Matrix Enzymes and Immune Cell Biology. | Front Mol Biosci | 2021 | 34527702 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9507/papers?page=36